Skip to content
Search

Latest Stories

Vaccine passports to be scrapped; PM Johnson to set out winter Covid-19 plan on Tuesday

Prime minister Boris Johnson will set out on Tuesday (September 14) his plans to manage the Covid-19 pandemic in the winter months, announcing a decision to scrap the introduction of vaccine passports and steps to end some emergency powers.

Johnson, under fire from some in his governing Conservative Party for raising taxes to fix a health and social care crisis, looks set to try to soothe those critics by ditching plans to introduce passports despite an increasing number of coronavirus cases.


Speaking to broadcasters, health secretary Sajid Javid said he did not anticipate more lockdowns and that the vaccine passports would not be introduced in England, as the government depends instead on vaccines and testing to defend the public.

"Now that we're entering autumn and winter... the prime minister this week will be setting out our plans to manage Covid over the coming few months and in that we will be making it clear that our vaccine programme is working," Javid told Sky News.

He told the BBC he was not "anticipating any more lockdowns" but would not take the measure off the table, that the government would not go ahead with vaccine passports to allow people to attend mass events and he wanted to "get rid of" PCR tests for travellers as soon as possible.

'Lot of virus around'

Javid added the government would remain "cautious", but "the vaccine programme, our testing programme, our surveillance programme, the new treatments... this is all our wall of defence and whilst there's a lot of virus around, it is working".

The night-time industry welcomed the U-turn on vaccine passports, with Michael Kill, the chief executive of the Night Time Industries Association (NTIA) trade body, saying he hoped businesses would be able to "start to rebuild a sector that has consistently been at the sharp end of this pandemic".

The government also said it expected Britain's Joint Committee for Vaccination and Immunisation (JCVI) to confirm the details of a vaccination booster programme to begin this month.

Britain, which has one of the highest official Covid-19 death tolls in the world, has seen the number of cases climb over the last few months after easing restrictions in July, when the government first bet on vaccines to protect the public.

The government was handed sweeping emergency powers in March 2020 with the introduction of the Coronavirus Act, which included measures to shut down businesses, to close down sectors of the economy and the right to detain infectious people.

"These extraordinary times required necessary but intrusive measures. But I'm determined to get of rid of any powers we no longer need because of our vaccine defences," said Johnson in a statement.

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less